.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Medtronic
Citi
Federal Trade Commission
Boehringer Ingelheim
Cipla
Baxter
Cerilliant
Deloitte
Novartis

Generated: June 22, 2017

DrugPatentWatch Database Preview

NORMOZIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Normozide, and what generic Normozide alternatives are available?

Normozide is a drug marketed by Schering and is included in one NDA.

The generic ingredient in NORMOZIDE is hydrochlorothiazide; labetalol hydrochloride. There are thirty-one drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; labetalol hydrochloride profile page.

Summary for Tradename: NORMOZIDE

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list36
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NORMOZIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019046-001Apr 6, 1987DISCNNoNo► Subscribe► Subscribe
Schering
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019046-004Apr 6, 1987DISCNNoNo► Subscribe► Subscribe
Schering
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019046-002Apr 6, 1987DISCNNoNo► Subscribe► Subscribe
Schering
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019046-003Apr 6, 1987DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: NORMOZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019046-002Apr 6, 19874,066,755► Subscribe
Schering
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019046-003Apr 6, 19874,066,755► Subscribe
Schering
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019046-004Apr 6, 19874,012,444► Subscribe
Schering
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019046-001Apr 6, 19874,012,444► Subscribe
Schering
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019046-003Apr 6, 19874,012,444► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
AstraZeneca
Queensland Health
Federal Trade Commission
Accenture
Cantor Fitzgerald
Fish and Richardson
Mallinckrodt
Teva
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot